Announcements Trials
Browse Landscape

Status

Completed 5

Sponsor Class

OTHER 5INDUSTRY 5

Study Type

Interventional 6Observational 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 4Stomach Neoplasms 2Cardiovascular Diseases 2Hemorrhage 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Aspirin × Clear all
NCT04081831 2022-04-19

ENgAGE-HK

Bayer

Completed
99,999 enrolled
Gastrointestinal

Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT03904732 2021-02-01

PEACOCS

Bayer

Completed
2,000,000 enrolled
Gastrointestinal

Cardiovascular Diseases, Hemorrhage, Colorectal Neoplasms

NCT03603366 2020-10-05

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Bayer

Completed
1,028 enrolled
Gastrointestinal

Cardiovascular Diseases, Colorectal Neoplasms

NCT03579732 2020-09-29

ENgAGE-Taiwan

Bayer

Completed
4,710,504 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03743883 2020-06-01

ENgAGE-UK

Bayer

Completed
99,999 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡